ViacomCBS Appoints Raffaele Annecchino President and CEO, ViacomCBS Networks International
10.12.2020 17:00:00 EET | Business Wire | Press release
ViacomCBS, Inc. (NASDAQ: VIAC, VIACA) today announced that Raffaele Annecchino has been appointed President and CEO of ViacomCBS Networks International (VCNI), effective immediately. He succeeds David Lynn, who is stepping down and will depart the company following a transition period.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201210005567/en/
ViacomCBS has appointed Raffaele Annecchino President and CEO, ViacomCBS Networks International (VCNI) (Photo: ViacomCBS)
In his new role, Annecchino will oversee all of ViacomCBS’s media networks and related businesses outside the U.S. As part of this, he will be responsible for a portfolio of pay-TV entertainment brands and broadcast networks across six continents – including Channel 5 in the UK, Telefe in Argentina, Network 10 in Australia and Colors in India through a joint venture with Viacom18 – and work closely with ViacomCBS’s global streaming organization to help guide the continued international rollout of Pluto TV and the launch of Paramount+ in 2021. He will report to Bob Bakish, President and CEO, ViacomCBS.
“Raffaele is an entrepreneurial, results-oriented leader with a proven ability to transform businesses and drive growth across diverse markets,” said Bakish. “In recent years, Raffaele has taken on increased responsibility, demonstrating strategic and operational expertise that extends across a wide variety of geographies and platforms. His experience in expanding ViacomCBS’s international footprint, forging key partnerships and accelerating our push into mobile and digital platforms will be critical to building on our leadership positions across Europe, Latin America and Asia and realizing our global ambitions.”
Bakish added, “I want to extend my deepest thanks to David for his many contributions over the past two decades, from integrating the international portfolios of CBS and Viacom to overseeing the launch of Viacom International Studios, including the acquisition of Ananey and repositioning the division to enable the continued expansion of our global streaming offerings. I’m grateful for his dedication and leadership and wish him the best as he starts this next chapter.”
“It’s an honor to step into this role and help continue ViacomCBS’s strong momentum around the world,” said Annecchino. “We have an exciting opportunity to broaden the company’s reach through new, innovative distribution channels and partnerships, and I look forward to working with Bob and the rest of the team to execute against our growth initiatives.”
Over the course of his 23-year tenure, Annecchino has held a number of positions across ViacomCBS Networks International, formerly Viacom International Media Networks (VIMN). Most recently, he served as President of ViacomCBS Networks Europe, Middle East, Africa and Asia (EMEAA), during which time he oversaw operations across a range of markets and led and coordinated VCNI’s mobile strategy globally. Among his achievements were the launch and acquisition of free-to-air channels in the key markets of Italy, Spain and Germany, and the creation of a new business unit in September 2020 to help drive ViacomCBS’s digital businesses across the EMEAA region, including capturing opportunities across free and pay streaming, advanced advertising and ViacomCBS Digital Studios International. Annecchino also led the expansion of Pluto TV in Europe with the recent successful launch of the service in Spain and the upcoming roll out in France and Italy in 2021.
Prior to joining MTV Networks International in 1997, Annecchino held positions at Turner International, Cartoon Network and CNN. He holds a Bachelor of Economics from the European Business School, London, UK, and an Executive MBA from the Instituto de Empresa International, Madrid, Spain. He completed the CTAM U Executive Management Program at Harvard Business School in 2016 and the CTAM Europe Executive Management Program at INSEAD in 2017.
Lynn commented, “It’s been an honor and a privilege to spend the greatest part of my career at ViacomCBS. From my early days at Comedy Central and Nickelodeon to more recently managing teams across our global portfolio, I’ve benefitted from working with the most dynamic, talented team in the industry – who in this most challenging year succeeded in transforming the business for the next important phase of growth.”
As President and CEO of VCNI and, before that, VIMN, Lynn was responsible for numerous strategic growth initiatives to diversify the company’s international business, which led to a significant increase in the company’s digital advertising and subscription revenues, among other achievements. As part of this, Lynn oversaw the launch of Viacom International Studios and the international rollout of Pluto TV and Noggin. Previously, he served as President of VIMN UK, Northern and Eastern Europe, where he oversaw Viacom’s global distribution strategy and led the acquisition of Channel 5 Broadcasting and its integration into Viacom. Before that, he was SVP, Managing Director, for Nickelodeon UK, where he strengthened its position in one of the UK’s most competitive viewing demographics, launching Nick Jr. and kick-starting its digital strategy.
About ViacomCBS
ViacomCBS (NASDAQ: VIAC; VIACA) is a leading global media and entertainment company that creates premium content and experiences for audiences worldwide. Driven by iconic consumer brands, its portfolio includes CBS, Showtime Networks, Paramount Pictures, Nickelodeon, MTV, Comedy Central, BET, CBS All Access, Pluto TV and Simon & Schuster, among others. The company delivers the largest share of the U.S. television audience and boasts one of the industry’s most important and extensive libraries of TV and film titles. In addition to offering innovative streaming services and digital video products, ViacomCBS provides powerful capabilities in production, distribution and advertising solutions for partners on five continents.
For more information about ViacomCBS, please visit www.viacomcbs.com and follow @ViacomCBS on social platforms.
ViacomCBS Networks International
ViacomCBS Networks International, a unit of ViacomCBS Inc. (NASDAQ: VIAC), comprises many of the world’s most iconic entertainment brands, including Network 10, Channel 5, Telefe, Viacom 18, ViacomCBS International Studios, Nickelodeon, MTV, Comedy Central, BET, Paramount Network and Pluto TV. In addition to offering innovative streaming services and digital video products, ViacomCBS Networks International provides powerful capabilities in production, distribution and advertising solutions for partners on five continents and across more than 180 countries.
VIAC-IR
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20201210005567/en/
Contact information
Media:
Kate Laverge
Senior Vice President, Communications, ViacomCBS Networks International
kate.laverge@viacom.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 12:47:00 EEST | Press release
Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food products. Within this inspiring premise, Good Food Makers confirms itself as one of the main levers f
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 11:16:00 EEST | Press release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 09:00:00 EEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 09:00:00 EEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin ® Epiduo ® Acne Gel Prescription-to-OTC Switch22.5.2026 19:25:00 EEST | Press release
Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) use in ages 12 years and older, marking a significant Prescription-to-OTC transition in acne care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522074280/en/ The U.S. FDA approves Differin® Epiduo® Acne Gel Prescription-to-OTC switch This milestone represents yet another example of Galderma’s unique Integrated Dermatology strategy, demonstrating how proven innovations from its Therapeutic Dermatology portfolio can further strengthen its Dermatological Skincare offerings. The Prescription‑to‑OTC transition highlights Galderma’s scale and expertise in successfully commercializing dermatology innovations across the full spectrum of acne care. With the appro
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
